Aslam F, Haque A, Foody J, Lee LV Peripheral arterial disease: current perspectives and new trends in management. South Med J. 2009 Nov;102(11):1141-9. doi: 10.1097/SMJ.0b013e3181bb9ab8. Review.
Carrero JJ, López-Huertas E, Salmerón LM, Baró L, Ros E Daily supplementation with (n-3) PUFAs, oleic acid, folic acid, and vitamins B-6 and E increases pain-free walking distance and improves risk factors in men with peripheral vascular disease. J Nutr. 2005 Jun;135(6):1393-9.
Cohn JN, Duprez DA, Grandits GA Arterial elasticity as part of a comprehensive assessment of cardiovascular risk and drug treatment. Hypertension. 2005 Jul;46(1):217-20. Epub 2005 May 2. Review.
Goodfellow J, Bellamy MF, Ramsey MW, Jones CJ, Lewis MJ Dietary supplementation with marine omega-3 fatty acids improve systemic large artery endothelial function in subjects with hypercholesterolemia. J Am Coll Cardiol. 2000 Feb;35(2):265-70.
Hall WL Dietary saturated and unsaturated fats as determinants of blood pressure and vascular function. Nutr Res Rev. 2009 Jun;22(1):18-38. doi: 10.1017/S095442240925846X. Epub 2009 Feb 26. Review.
Hill AM, Buckley JD, Murphy KJ, Howe PR Combining fish-oil supplements with regular aerobic exercise improves body composition and cardiovascular disease risk factors. Am J Clin Nutr. 2007 May;85(5):1267-74.
Johnson GH, Keast DR, Kris-Etherton PM Dietary modeling shows that the substitution of canola oil for fats commonly used in the United States would increase compliance with dietary recommendations for fatty acids. J Am Diet Assoc. 2007 Oct;107(10):1726-34.
Keogh JB, Grieger JA, Noakes M, Clifton PM Flow-mediated dilatation is impaired by a high-saturated fat diet but not by a high-carbohydrate diet. Arterioscler Thromb Vasc Biol. 2005 Jun;25(6):1274-9. Epub 2005 Mar 17.
Lane HA, Smith JC, Davies JS Noninvasive assessment of preclinical atherosclerosis. Vasc Health Risk Manag. 2006;2(1):19-30. Review.
Lane JS, Magno CP, Lane KT, Chan T, Hoyt DB, Greenfield S Nutrition impacts the prevalence of peripheral arterial disease in the United States. J Vasc Surg. 2008 Oct;48(4):897-904. doi: 10.1016/j.jvs.2008.05.014. Epub 2008 Jun 30.
Mukherjee D, Cho L Peripheral arterial disease: considerations in risks, diagnosis, and treatment. J Natl Med Assoc. 2009 Oct;101(10):999-1008. Review.
O'Keefe JH Jr, Abuissa H, Sastre A, Steinhaus DM, Harris WS Effects of omega-3 fatty acids on resting heart rate, heart rate recovery after exercise, and heart rate variability in men with healed myocardial infarctions and depressed ejection fractions. Am J Cardiol. 2006 Apr 15;97(8):1127-30. Epub 2006 Mar 3.
Simon A, Chironi G, Levenson J Comparative performance of subclinical atherosclerosis tests in predicting coronary heart disease in asymptomatic individuals. Eur Heart J. 2007 Dec;28(24):2967-71. Epub 2007 Oct 29. Review.
Stamatelopoulos K, Karatzi K, Sidossis LS Noninvasive methods for assessing early markers of atherosclerosis: the role of body composition and nutrition. Curr Opin Clin Nutr Metab Care. 2009 Sep;12(5):467-73. doi: 10.1097/MCO.0b013e32832f0d99. Review.
Tóth PP An urgent matter-identifying your patients' cardiovascular risk and improving their outcomes. Atherosclerosis: the underlying disease. J Fam Pract. 2009 Nov;58(11 Suppl Urgent):S19-25. Review.
Wang X, Keith JC Jr, Struthers AD, Feuerstein GZ Assessment of arterial stiffness, a translational medicine biomarker system for evaluation of vascular risk. Cardiovasc Ther. 2008 Fall;26(3):214-23. doi: 10.1111/j.1755-5922.2008.00051.x. Review.
Zahradka P, Guzman R, Weighell W, Wright B, Baldwin A, Louis S, et al Increased consumption of legumes improves arterial stiffness in peripheral vascular disease independent of blood pressure, weight and serum cholesterol. Experimental Biology '09, April 18-22, New Orleans, LA 2009.
Effects of Canola Oil on Blood Vessel Function in Peripheral Arterial Disease (PAD)
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.